Logo-npj
J Nephropharmacol. 2017;6(2): 49-61. doi: 10.15171/npj.2017.04

Mini-Review

Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysis

Wisit Cheungpasitporn 1 * , Charat Thongprayoon 2, Karn Wijarnpreecha 2, Ankit Sakhuja 3, Wonngarm Kittanamongkolchai 1, Jackrapong Bruminhent 4

Cited by CrossRef: 1


1- Bashir A, Verma A, Duseja A, De A, Tiwari P. Adjuvant Use of Ribavirin With Treatment of Hepatitis C Virus in Kidney Transplant Recipients. 2022;16(3):243 [Crossref]